30 June 2026
Hogan Lovells advises Definium Therapeutics, Inc. in Upsized Public Offering
Advising firms
Deal team
9 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Steve Abrams Lead | Hogan Lovells Cadwalader | Partner | Capital Markets | Philadelphia |
| Val Delp | Hogan Lovells Cadwalader | Counsel | Capital Markets | Denver |
| Tyler Glass | Hogan Lovells Cadwalader | Senior associate | Capital Markets | Philadelphia |
| Kayvon Paul | Hogan Lovells Cadwalader | Associate | Capital Markets | Philadelphia |
| Henry Kahn | Hogan Lovells Cadwalader | Counsel | M&A | Baltimore |
| Steven Kaufman | Hogan Lovells Cadwalader | Partner | M&A | Washington, D.C. |
| Caitlin Piper | Hogan Lovells Cadwalader | Partner | Tax, Pensions & Benefits | Washington, D.C. |
| Sally Gu | Hogan Lovells Cadwalader | Partner | Pharmaceuticals and Biotechnology | Washington, D.C. |
| Katherine Kramer | Hogan Lovells Cadwalader | Associate | Pharmaceuticals and Biotechnology | Washington, D.C. |
6 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 805m (US$805 million)
- What the figure measures
- Issue size
- Client
- Definium Therapeutics, Inc.Issuer
- Counterparties
- Not stated